EGFR and glioblastoma: Another autophagy inhibitor, chloroquine, has been tested in both pre-clinical glioblastoma studies as well as dose evaluation in a clinical trial.389 Pre-clinical studies have shown that chloroquine efficacy may be enhanced in EGFR-mutant glioblastoma, due to increased dependency on autophagy.